Hyperlipidemia and atherasclerosis Flashcards

1
Q

what is hyperlipidemia

A

Elevated levels of lipids (TAG & cholesterol) in the blood

Forms initial phase for the progression of atherosclerosis

Asymptomatic and therefore gets unnoticed until late

TAG & cholesterol play essential roles in the body but their defects lead to pathological conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is primary hyperlipidemia

A

mainly due to genetic deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is secondary hyperlipidemia

A

– due to lifestyle and other metabolic diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is lipoproteins
what is its role
how many categories do they have?

A

Lipids + proteins (noncovalently associated)
Transport vehicles for triacylglycerols and cholesterol
Classified into 5 broad categories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the 5 broad categories of lipoproteins

A

HDL
Transport endogenous cholesterol from tissues to liver

VLDL, IDL & LDL
Transport endogenous TAG & cholesterol from liver to tissues (liver produces TAG from excess CHO)

Chylomicrons
Transport exogenous TAG & cholesterol from intestines to tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the structure of lipoproteins like?

A

Nonpolar core: triacylglycerols and cholesteryl esters
Amphiphilic surface: Apoproteins, phospholipid & cholesterol

ApoB48: Intestine; Apo B-100: Liver
Lipoprotein from intestine is secreted into lymph
Lipoprotein from liver is secreted into plasma
Apoproteins E, CII & CIII may also come from HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the causes of hyperlipidemia?

A

Mostly multifactorial including nutrition, genetics, medications & metabolic diseases (e.g. diabetics & obesity)

Genetic causes include; increased sensitivity to dietary cholesterol, lack of LDL receptors, mutations in LDL and ABCA1 receptors and apoproteins and over synthesis of apoproteins

Primary hypercholesterolaemia: genetic cause; deficiency or defect in LDL receptors (e.g. familial hypercholesterolaemia)

Secondary hypercholesterolaemia: associated with metabolic diseases (e.g. type II DM) & lifestyle (e.g. high calorie diet & inactivity)
Diets rich in TAG & saturated FAs increase cholesterol synthesis & suppress LDL receptor activity
Other metabolic conditions that increase cholesterol levels; BP, hypothyroidism, nephrotic syndrome & obstructive liver diseases
Medications; β-blockers, estrogens and protease inhibitors (HIV)

Hypertriglyceridaemia: can lead to pancreatitis & eruptive xanthoma
Primary - familial hypertriglyceridaemia (deficiency LPL& apoCII)
Secondary – similar to above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the diagnosis of hyperlipidemia?

A

No obvious symptoms in most cases
Blood test is recommended in fasting conditions
Should be tested regularly for >40 years old; with family history of CVDs; obesity & diabetes or other metabolic diseases; hypertension

Total serum cholesterol
Normal range 
3.5-6.5 mmol/L
UK average is 5.6 mmol/L
Target 
<5 mmol/L
<4 mmol/L if at high risk or have CVD

HDL cholesterol (male)
0.8-1.8 mmol/L
>1.0 mmol/L if at high risk or have CVD

HDL cholesterol (female)
1.0-2.3 mmol/L
>1.0 mmol/L if at high risk or have CVD

LDL cholesterol (fasting)
<4 mmol/L
<3 mmol/L
<2 mmol/L if at high risk or have CVD

Triglycerides (fasting)(male)
0.7-2.1 mmol/L
<1.7 mmol/L

Triglycerides (fasting)(female)
0.5-1.7 mmol/L
<1.7 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the non pharmacological treatments for hyperlipidemia?

A
Healthy balanced diet (replace saturated fat diets with fruits/ vegetables) – avoid or reduce animal fats 
Regular intake of Omega-3 FAs (avocados and oily fish e.g. salmon) 
Regular exercise (weight loss), limiting alcohol intake & avoid smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the pharmacological treatment option for hyperlipidemia?

A

Medications
Statins: Inhibit cholesterol biosynthesis (HMG-CoA reductase)
Different types: atorvastatin, simvastatin and rosuvastatin
Should be prescribed only to people at high risk for CVDs
Taken for life long as it can reverse the cholesterol if stopped

Aspirin: Anti-platelet drug that inhibits platelet activation
Should be prescribed with a low dose for people at high risk
Periodic blood test is required to check the liver functions

Ezetimibe: Blocks the absorption of cholesterol from food and bile
Reduced side effects compared to statins
Can be taken on its own when statins can’t be prescribed
Taken as a combination with statins if the level is not reduced

Bile acid sequestrants: Binds to bile acid in small intestine and thus increase release of from the liver and reduce cholesterol
Bile acid sequestrants available in the UK include: colesevelam (tablets), colestyramine (resin), colestipol (resin)
May interefere with the absorption of lipid soluble nutrients

Fibrates: PPARα agonists that induce hepatic uptake and oxidation of cholesterol & TAG, and adipogenesis
bezafibrate, ciprofibrate, fenofibrate, gemfibrozil
Can be given when patients cannot take statins

Nicotinic acid or niacin or vitamin B3: Inhibits lipolysis in adipocytes and reduce lipid synthesis in the liver
Usually high concentrations are required
Associated with several side effects such as vasodilation, skin rash, hepatotoxicity and hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is atheroscleorsis?

A

Arteriosclerosis – hardening of arteries due to non-plaque factors
Hyperlipidaemia leads to the development of atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the different stages of progression of atherscleoris?

A

Different stages of progression

  1. Endothelial cell injury
  2. Migration of LDLs
  3. Adhesion, migration & transformation of monocytes
  4. Engulfing ox-LDLs
  5. Migration and proliferation of SMCs
  6. Expansion and occlusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does rupture of plaque cause?

A

Rupture of plaque leads to thrombotic events

Should be treated promptly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the structure of an artery wall?

A
Tunica intima (inner coat): endothelium, connective tissue & internal elastic membrane
Tunica media (middle coat): smooth muscle cells
Tunica externa (outer coat): collagen & elastic fibres
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

explain the development of atherosclerosis?

A

1) Endothelial cell injury
Elevated LDL levels, smoking, immune mechanisms and mechanical stress due to hypertension
These cause irritation or damage or dysfunction to endothelial cells

2)Migration of LDLs
Endothelial dysfunction allows the migration of excessive LDL into intima
LDLs get oxidised by ROS produced from ECs, SMCs and macrophages at later stages

3) Adhesion, migration & transformation of monocytes
Damaged endothelium expresses P-selectin & signalling molecules to attract monocytes to the damaged region
Monocytes adheres to P-selectin on EC and migrate into the intima and transform into macrophages

  1. Engulfing ox-LDLs
    Macrophages engulf all the ox-LDLs and become foam cells
    This enhances the HDL reverse cholesterol transport, however, continuous accumulation leads to further development of fat streak
    Macrophages & Foam cells release growth factors
  2. Migration and proliferation of SMCs
    Growth factors enhance the migration and proliferation of SMCs
    SMCs form fibrous cap with collagen, elastin, etc.
    SMCs calcify the fibrous cap and harden this heavily
    Dead cells release the lipid core
  3. Expansion and occlusion
    Initially the plaque grows towards the Tunica externa
    Then grows towards the lumen
    At a final stage, plaque can rupture and activate platelets and lead to thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the risk factors of atherscleorosis

A

Unchangeable factors
Family history
Other genetic factors
Ageing

Poor diet (high calorie, fat)				
Heavy stress
Gender (male)				
Alcohol
Medications  
Physical inactivity
Modifiable factors  
Hyperlipidaemia 
Metabolic diseases (e.g. DM & obesity)
Smoking 
Hypertension
17
Q

what are the methods for diagnosing atheroscleoris?

A
- blood test 
ecg
echocardiogram 
angiogram
CT scan
18
Q

what are the treatments for atherscleorosis?

A

Same as for hyperlipidaemia
Anti-hypertensives: ACE inhibitors, calcium channel blockers & diuretics
Anti-platelet drugs to prevent thrombosis
Surgical procedures

19
Q

what are the possible surgical procedures for atherscleorisis?

A
Coronary angioplasty - balloon/stent
CABG- coronary artery bypass graft 
Carotid angioplasty- stent
Carotid endarterectomy- cut open and remove the plaque and stitch back up
Extracranial to intracranial bypass
20
Q

what are the function of lipoprotein - step by step

A

Chyme (mixture of gastric juice and partially digested food) enters small intestine (duodenum)

It induces the release of bile (from liver) and digestive enzymes (includes lipases) & HCO3 (neutralises pH) (from pancreas) into the duodenum

Fat droplets can form aggregates and this prevents the digestion by lipases

Bile prevents the formation of lipid aggregates by binding to fat droplets and forming micelles (bile-hydrophilic end at the surface and hydrophobic inside the micelles)

Lipase breaks down micelles into FAs and monoglycerides and these pass through the intestinal mucosa and enter epithelial cells

These molecules enter ER and resynthesised as TAG

Cholesterol is transported through specific channels

TAG with cholesterol, phospholipid and proteins forms chylomicrons

Proteins on chylomicrons makes them water soluble and facilitate exocytosis

So they can leave mucosal cells through exocytosis and transported through lymphatic vessel into the thoracic duct and enters into the subclavian vein

21
Q

what is the role of chylomicrons

A

Intestine – Lymphatic system – Thoracic duct – Circulation
Apoprotein C II activates LPL in capillaries and thereby release FAs and glycerol from TAG into muscles and adipose tissues
In adipose tissues stored as TAG again

22
Q

what is the role of VLDL/IDL/LDL

A

VLDL – Liver – Circulation
C II activates LPL and release FAs and glycerol from TAG
Becomes smaller, IDL
HL (hepatic lipase) removes remnant FAs from IDL and forms LDL
LDL rich in cholesterol travel back to liver
LDLr or LRP (LDL-r related P) binds and take up LDL through endocytosis

23
Q

what is the role of HDL

A

Reverse cholesterol transport – from peripheral cells to liver

Synthesised and released as lipid free Apo-A1 (HDL) from intestine & liver
Apo-A1 covers around 70% of protein content in HDL
In circulation, get contact with foam cells/macrophages/other peripheral cells
Hydrolase converts CE into free C and ABCA1 transports free C to the cell membrane from the lipid pool
Apo-A1 binds to ABCA1 receptor and acquires cholesterol and become a nascent HDL
LCAT (lecithin cholesterol acyltransferase) esterifies the free C on the surface of HDL and then CE moves to the core of HDL (HDL3)
Then interacts with ABCG1 & SR-B1 and acquires more cholesterol and becomes mature HDL (HDL2)

HDL also collects C from the cell membranes and caveoli
HDL delivers cholesterol to the liver through 2 pathways; direct (via SR-B1) and indirect (via LDL)
Through SR-B1 directly delivers cholesterol in to the liver cells
Lipid-free HDL returns to circulation and repeat the process
Indirect pathway via cholesterol ester transfer protein (CETP) which facilitates direct exchange of CE with TAG between HDL and VLDL/LDL
LDL delivers cholesterol to the liver through LDL receptors or LRP
Cholesterol is excreted as bile via intestine or formed as TAG
HDL can also be degraded in the liver